Articles

Expertise

Recognized tradition of competences and capabilities for conceiving development strategies for innovative compounds and for planning, conducting and reporting clinical trials from FTIM to Phase IV

Extensive experience in oncology clinical development from cytotoxics to hormonals and targeted therapies:

INDICATIONS
  • Acute Leukemia
  • Chronic Leukemia
  • Multiple Myeloma
  • Myelodisplastic Syndromes
  • Non-Hodgkin Lymphoma
  • Glioblastoma
  • Breast
  • Colorectal
  • Head/Neck
  • Hepatocellular
  • Lung
  • Melanoma
  • Mesothelioma
  • Ovarian
  • Pancreatic
  • Prostate
  • Soft Tissue Sarcoma
  • Thymic Carcinoma
THERAPEUTICS
  • Chemotherapeutics
    • Anthracycline/Anthracenediones
    • Antimetabilites
    • Topo 1 Inhibitors
  • Hormones
  • Cytokines
  • Growth Factors
  • Small Molecules
  • Antibodies


ROUTE OF DELIVERY

  • Systemic
  • Loco-Regional
  • Oral
 
To give you a better browsing experience, NMS Group and Group Companies use own and third part cookies.
Browsing this web site, you allow to use them, according to our  
Cookie Policy.